feed,title,long_url,short_url
SeekingAlpha,AIM ImmunoTech commences phase 2 study of Ampligen for treatment of pancreatic cancer,https://seekingalpha.com/news/3874651,
SeekingAlpha,"Curis, Allarity top healthcare gainers; Blue Water, Accelerate Diagnostics lead losers' pack",https://seekingalpha.com/news/3874650,
SeekingAlpha,NewAge receives Nasdaq notice for non-compliance,https://seekingalpha.com/news/3874649,
SeekingAlpha,Existing homes sales fall 5.9% in July,https://seekingalpha.com/news/3874648,
SeekingAlpha,Optex Systems stock climbs on tender offer for $4.25M shares,https://seekingalpha.com/news/3874647,
SeekingAlpha,89bio completes enrollment in phase 2 trial for NASH treatment,https://seekingalpha.com/news/3874646,
SeekingAlpha,DCP Midstream shoots higher after Phillips 66's buyout offer,https://seekingalpha.com/news/3874652,
